Gene Editing Trial assesses the impact of two immunomodulators in reducing CV risk among rheumatoid arthritis patients Posted on December 5, 2022 by Editorial Staff People with rheumatoid arthritis are at increased risk of cardiovascular (CV) disease, with studies indicating an approximate 50 percent increase in risk of CV events such as heart attack and stroke. Share on FacebookTweetFollow us Editorial Staff New machine learning algorithm could spot early signs of pneumonia based on cough sounds Study shows addiction potential and health risks of alternatives to menthol cigarettes